Fundraising Fox

Mary Wheeler

Investor

Managing Director at BioRock Ventures

Bay Area, CA

About

Founding managing partner of BioRock Ventures with two decades of therapeutics operating experience, beginning as a startup founder in Boston and later leading M&A, licensing, and strategy at pharmaceutical companies including Johnson & Johnson and Forest (now Allergan/AbbVie). She has consulted as CBO for dozens of early-stage ventures and, over the past decade, helped seed two companies that each achieved IPO exits valued over $1 billion. She is a Kauffman Fellow with an MBA from MIT Sloan, a PhD from Princeton, and an undergraduate degree from Yale.

Experience

  1. BioRock VenturesInvestor, Founding Managing Director, GPcurrent2019 β€” presentSan Francisco Bay Area
  2. AngelListInvestor AngelList Syndicate, Therapeutics2017 β€” 2021
  3. Seed, Series A biotechnology, life sciences and food tech companiesChief Business Officer/Advisor/Consultant to startups and growing companies2014 β€” 2021California, NY, Canada, Australia, China
  4. StartX;IndieBio; ELabNYC; Other AcceleratorsMentor2014 β€” 2020California, Canada and NYC
  5. Kauffman Fellows ProgramKauffman Fellow, Class 182013 β€” 2015Palo Alto, CA
  6. Johnson & JohnsonInnovation Center, New Venture Partnerships and Transactions2013 β€” 2014Menlo Park, Ca
  7. Forest Laboratories (Allergan | Abbvie)M&A, Licensing and Strategic Planning2008 β€” 2012New York, NY
  8. Ariston Pharmaceuticals (now part of Pfizer)Co-Founder, CBO2004 β€” 2008Boston, Massachusetts, United States

Education

  1. Yale UniversityBachelor of Arts - BA
  2. MIT Sloan School of ManagementMBA, New Product and Venture Development Track - Entrepeneurship
  3. Princeton UniversityPhD, cognitive neuroscience
  4. Kauffman Fellows Class 18Venture Capital Investing, Entrepreneur Mentorship2013 β€” 2015
  5. MIT Sloan School of Management

Skills & more

CEO supportCEO SuccessionLicensing NegotiationsBoard LevelStrategy6Working with InvestorsNew Venture FormationNew Business DevelopmentConsultingContract ManagementBusiness Case ModellingNew Venture Development
+12 moreContract DraftingAngel InvestingBiopharmaceuticalsContract NegotiationBiotechnologyVenture CapitalMergers & AcquisitionsStart-upsLife SciencesLicensingStrategic PlanningNegotiation

From Mary's professional profile.

Same school

Shared employers

Deals Β· 2

AN2Solo GP

via BioRock Ventures

Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.